Bicyclic heterocycles as FGFR inhibitors
US11530214B2 · kind B2 · utility
4Cited by
68References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2021 |
| Grant date | Dec 20, 2022 |
| Priority date | — |
| Expiry date | Jan 28, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.